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Purpose. The increased prevalence of patent foramen ovale in
patients with cryptogenic strokes suggests the occurrence of
paradoxical embolism. The identification of deep venous
thromboses (DVTs) in this population would strengthen this
hypothesis. The purpose of this study was to image the
subdiaphragmatic venous system in a cohort of patients with
cryptogenic strokes. Materials and Methods. In 37 patients with
cryptogenic brain ischemia and interatrial communication,
duplex studies of calf, popliteal, and femoral veins, and mag-
netic resonance imaging venograms of the pelvis veins were
performed. Results. In 10 patients, DVTs were diagnosed that
were considered to be the cause of cryptogenic brain ischemia
on probable (n = 6) or possible (n = 4) bases. In these patients,
the median time from stroke to DVT was 3.25 days. In 5 of these
10 patients, DVTs did not involve popliteal and femoral veins,
areas thought most important to pulmonary embolism, but
instead were isolated to calf or pelvic veins. Although none of
these 10 patients had abnormal blood hypercoagulation tests, 8
of the 10 did have clinical conditions suggesting predisposition
to developing DVTs, such as concomitant neoplasms or pulmo-
nary embolism. Conclusions. Increased evidence for paradoxi-
cal embolism may emerge when diagnostic strategies use multi-
ple imaging methods and evaluate a broad extent of the
subdiaphragmatic veins.
Key words: Cryptogenic stroke, paradoxical embolism, deep
venous thrombosis, patent foramen ovale.
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No cause can be identified in 26% to 40% of all ischemic
strokes1-3 and in 64% of patients under age 55.4 Such cases
have been termed cryptogenic strokes. A better understand-
ing of stroke pathophysiology in these patients could be
important to improving secondary stroke prevention.
Although a number of different processes likely con-
tribute to cryptogenic stroke, several lines of evidence
suggest that paradoxical embolism through a patent fora-
men ovale (PFO) is one important subgroup. The preva-
lence of PFOs in patients with cryptogenic strokes is 42%
to 73%, significantly higher than controls or patients with
strokes of determined origins.5-8 Brain imaging in this
population suggests embolic strokes.1,9 The rate of stroke
increases with larger PFO size; for example, several
studies9-14 have suggested that in patients with cryptogenic
strokes, the sizes of the interatrial shunts are larger than in
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patients with strokes of determined origins or in normal
controls. The risk for PFO-related stroke is further
increased when an atrial septal aneurysm is also pres-
ent,5,15 though the presence of an atrial septal aneurysm
may in part be a reflection of larger PFO size.16
Cryptogenic stroke in the presence of an interatrial
shunt is a common clinical scenario, but the fraction of
cryptogenic strokes accounted for by paradoxical embo-
lisms remains uncertain because a venous source of
embolic material has not been identified. The increased
detection of deep venous thromboses (DVTs) in patients
with cryptogenic strokes and PFOs might be achieved by
using multiple diagnostic modalities and by evaluating all
subdiaphragmatic veins. The current study reports the
results of combined duplex and magnetic resonance
imaging (MRI) evaluation of the subdiaphragmatic
venous system in a cohort of 37 patients with
cryptogenic brain ischemic events plus right-to-left
intracardiac communication.
Patients and Methods
During the service time of 2 physicians (SCC, WSB), a ve-
nous system study was performed as part of clinical evalu-
ation in 37 patients with interatrial shunts and cryptogenic
brain ischemic events. Events were labeled cryptogenic
only after the normal evaluation of extracranial and
intracranial arteries and echocardiography. Of the 37 pa-
tients, 6 were from the University of Texas, Houston (UT),
and 31 were from the University of Washington (UW).
The mean (±SD) age was 54 ± 16 years (range, 22-80
years). There were 25 female and 12 male patients. Arte-
rial studies used Doppler methods in 19 patients, mag-
netic resonance angiograms in 7, catheter angiograms in
5, and 2 or more of these methods in 6. Echocardiograms
were transesophageal in 20 patients and transthoracic in
17 patients. PFOs were present in 35 patients, 5 of whom
had concomitant atrial septal aneurysms, while 2 patients
had atrial septal defects (ASDs).
Among these 37 patients, the median time from cere-
bral ischemic event to the first study of the venous system
was 8 days. At the time of venous system evaluation, 23
patients were receiving antiplatelet agents, 9 were receiv-
ing anticoagulation, 2 were receiving both, 1 was < 24
hours after intravenous tissue plasminogen activator, and
2 were receiving no treatments related to thromboses.
There were 22 inpatients and 15 outpatients. Brain
ischemia was transient ischemic attacks in 6 patients and
strokes in 31.
Venous system evaluation included leg vein duplex
and pelvic vein magnetic resonance venography (MRV).
Venous duplex exams included the evaluation of the bilat-
eral deep femoral, superficial femoral, and popliteal
veins. At UW, duplex exams also included the tibial,
saphenous, and peroneal veins.
Pelvic MRV included time-of-flight (TOF) and phase-
contrast (PC) imaging using a torso coil at 1.5 T, without
the introduction of contrast. The field of view extended
from the infrarenal inferior vena cava to the proximal
common femoral vein. For TOF images, slices were 3 mm
thick with 2-mm skips between slices. For PC images,
slices were 5 mm thick with no skips and were in plane
with TOF slices.
Pelvic MRV images were reviewed by 2 radiologists
specializing in abdominal-pelvic imaging who were
blinded to all patient clinical data. The final read for the
study was either positive or negative for acute pelvic
DVT, on the basis of consensus opinion. MRV was
deemed positive for acute DVT when both radiologists
identified a 15-mm or longer intravascular decrease in sig-
nal intensity on TOF images that contacted the wall of the
vein. The intravascular signal decrease on PC images was
required to match the TOF abnormality.
A paradoxical embolism was considered to be the
cause on a probable basis when 2 criteria were met: (1)
DVT was documented < 4 days after or up to 1 week prior
to the cerebral ischemic insult, and (2) a PFO or an ASD
was demonstrated on echocardiogram. Four days
poststroke was chosen in defining probable paradoxical
embolism because the incidence of poststroke DVT rises
significantly after this time.17 A paradoxical embolism was
considered as being the possible cause of the cryptogenic
brain ischemic event when a PFO or an ASD was present,
and many features were suggestive of a paradoxical
embolism, but the first criterion was not completely met.
An acute DVT was excluded from either category if diag-
nosed ≥ 4 days poststroke in a patient with hemiplegia.
Results
A total of 14 of 37 patients were diagnosed with DVTs.
Five of these were in the pelvic veins, including 1 patient
from UT, and 9 of these were in the leg veins, including 1
patient from UT. In 4 of these 14 patients, the DVTs were
determined to be consequences of strokes because of ei-
ther hemiplegia, DVTs arising after normal poststroke leg
duplex exams, or the chronic appearance of DVTs when
imaged early after stroke. In the other 10 of these 14 pa-
tients, paradoxical embolisms were determined to be the
cause of cryptogenic brain ischemia on probable or possi-
ble bases. Note that MRV was not performed in 7 of 37 pa-
tients for a number of reasons, including MRI availability,
claustrophobia, or the diagnosis of calf DVTs.
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Among the 10 patients with possible or probable para-
doxical embolisms (Table 1 and Fig 1), the mean age was
55 ± 17 years (range, 27-78 years), and the median time
from stroke to DVT diagnosis was 3.25 days. There were
5 female and 5 male patients. At the time of venous system
evaluation, 5 were receiving antiplatelet agents, 3 were
receiving anticoagulation, 1 was receiving both, and 1 was
receiving no treatments related to thrombosis. Note that
the DVTs in 5 of 10 patients were restricted to calf or pel-
vic veins. No blood hypercoagulable tests were abnormal
in these 10 patients, including negative results on testing
IgG and IgM anticardiolipin antibody in 6 patients, acti-
vated protein C resistance in 5, protein S in 7, protein C in
6, and antithrombin III in 6; lab error, the early initiation
of warfarin, and other factors prevented complete testing
in some patients. However, hypercoagulable states were
suggested in 8 of 10 patients’ histories: prior (2) or concur-
rent (1) pulmonary embolism, prior leg DVT, essential
thrombocytosis, rectal adenocarcinoma, melanoma, and
smoking while taking birth control pills.
In 3 patients, only TOF imaging was performed; in
none of these were images suggestive of possible or proba-
ble paradoxical embolisms. In 6 patients, the same field of
view was covered by a larger number of thinner MRI
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Table 1. Ten Patients With Probable or Possible Paradoxical Emboli as Cause of Cryptogenic Brain Ischemic Events (PFO size is
noted when available)
Clinical Venous Interatrial Cryptogenic Cerebral
Patient Age/Sex Features Thrombus Shunt Ischemic Event
Probable cases of paradoxical
embolism to the brain
1 27/M Sickle cell disease; history
PE; moderate
hemiparesis with stroke
L EIV DVT extending
to L CFV, 3 d
poststroke
PFO ACA cortical stroke
2 68/M Rectal melanoma;
postoperative TIAa
R calf DVT found 6 d
before, confirmed
1 d after, TIA
PFO TIA
3 57/M Thalamic abscess found 12 d
prestroke; PE diagnosed
3 d prestrokea
L calf DVT, 3 d
prestroke
Small PFO
and ASA
Multiple, simultaneous
cerebral and cerebellar
small strokes
4 51/F Essential thrombocytosis;
recent history benign
pelvic mass; multiple
prior embolic strokesa
Bilateral DVT from
calf veins to IVC,
first diagnosed
5 mo before, con-
firmed 3 d after, stroke
PFO Multiple, bilateral small
cortical strokes
5 78/M Stage III rectal
adenocarcinoma, with
resection 3 mo prestrokea
R CIV DVT, 3.5 d
post-CVA
PFO Parietal cortical CVA
6 54/F 4 y of birth control pills;
mild hemiparesis with
stroke
L saphenous vein DVT
extending to popliteal
vein, 2 d poststroke
Moderate
PFO
Frontal cortical CVA
Possible cases of paradoxical
embolism to the brain
7 78/F Prior porcine aortic valve
replacementa
L thigh DVT 10 mo
prestroke; R calf
chronic DVT 2 mo
poststroke
Moderate
PFO and
ASA
Large PCA stroke
8 57/F Prior cryptogenic stroke
TIA with concurrent PEa
L CIV DVT, 7 d post-
TIA/PE
PFO TIA
9 38/M R knee trauma and R
popliteal surgery
preceding strokea
Chronic DVT R
popliteal vein, first
diagnosed 12 mo
poststroke
PFO Basilar artery embolus
10 43/F Smoker on birth control
pillsa
R peroneal, posterior
tibial, and soleal vein
DVT, 6 d post-CVA
PFO and
ASA
Posterior inferior cerebellar
artery territory stroke
PFO = patent foramen ovale, M = male, PE = pulmonary embolus, L = left, EIV = external iliac vein, DVT = deep venous thrombosis, CFV = com-
mon femoral vein, ACA = anterior cerebral artery, TIA = transient ischemic attack, R = right, ASA = atrial septal aneurysm, F = female, IVC = inferior
vena cava, CIV = common iliac vein, CVA = cerebrovascular accident, PCA = posterior cerebral artery.
a. Indicates no motor deficits with cerebral ischemic event.
slices because of a technical error. Of these 6 patients, 1
was considered to have a possible, and none a probable,
paradoxical embolism.
Discussion
The majority of patients with cryptogenic strokes also
have PFOs, suggesting paradoxical embolisms as the ba-
sis of the strokes in some patients. However, a venous
source of thrombus has infrequently been identified, call-
ing into question whether PFOs are truly relevant to the
genesis of strokes.18 The current study identified 10 pa-
tients with cryptogenic brain ischemia plus right-to-left
intracardiac communication in whom DVTs were possi-
bly or probably the origin of paradoxical embolisms. Im-
portantly, half of these 10 DVTs were restricted to calf or
pelvic veins; that is, they did not involve popliteal or fem-
oral veins.
The prevalence of DVTs among patients with
cryptogenic strokes and interatrial shunts is unclear
because most previous studies did not consistently exam-
ine all subdiaphragmatic veins or were not restricted to
cryptogenic strokes. In studies of stroke patients with
PFOs but not restricted to cryptogenic strokes, DVTs
were found in 6% of an unspecified subset,19 5 of 53
patients (9.5%) with suspected cardioemboli,20 and 19 of
35 patients (54.3%) with cerebral emboli and in many
cases known causes of strokes.21 In 2 studies restricted to
patients with cryptogenic strokes, DVTs were found in 3
of 23 (13%)22 and 1 of 14 (7%)23 patients with PFOs. The
latter 4 studies each used bilateral contrast venography,
which may be less sensitive to DVTs in the pelvis as com-
pared to other sites.24,25
Pelvic veins may be an important and under-
appreciated source of thromboemboli. At autopsy, the
pelvic veins were the only source of paradoxical emboli in
19 of 86 patients (22%) in whom sources could be
found,26,27 and isolated pelvic DVTs were found in 16% of
patients with pulmonary emboli.28 Spritzer et al,29 in 769
consecutive MRV studies of the entire leg and pelvis,
found that DVTs isolated to the pelvic veins were more
common than in the calf veins and almost as common as
in the thigh veins. Other evaluation techniques may have
reduced diagnostic sensitivity for pelvic DVTs.24,30 Two
prior studies found MRV useful for the diagnosis of pelvic
DVTs in patients with strokes and interatrial communica-
tion.31,32
Calf veins may also be an important source of
thromboemboli in the setting of cryptogenic stroke. Iso-
lated calf vein DVTs are more common than DVTs in any
other site following stroke17,33 and at autopsy.34 Proximal
propagation may occur in 20% to 28% of calf vein
DVTs.35,36 Embolization can occur without propagation;
for example, isolated calf DVTs were found at autopsy in
36% to 46% of patients with pulmonary embolisms.37 In
general medical practice, calf vein thrombi are associated
with small emboli, any consequent pulmonary emboli
tend to be small and asymptomatic, and these DVTs are
therefore considered low risk for important pulmonary
events.38,39 As a result, anticoagulation is initiated only if
repeat testing shows proximal extension.40 However,
small thrombi that are associated with minor injuries to
the lung might have important effects on reaching cere-
bral arteries with diameters of 1 mm.41 Therefore, the
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Fig 1. (a) A positive calf vein duplex study in the long view
(left) and transverse view (right) from patient 3. One of the
paired gastrocnemius veins (large arrow) is dilated, has some
soft echogenicities, and did not compress. These features are
consistent with an acute deep venous thrombosis (DVT). The
other gastrocnemius vein (small arrow) and artery (double ar-
row) are normal in size, as is the popliteal vein (curved arrow).
(b) A positive pelvic magnetic resonance venography scan
from patient 8 showing the time-of-flight (TOF) (upper row)
and phase-contrast (PC) (lower row) pulse sequences. The
left common iliac vein has a site of decreased signal intensity
(long arrows) consistent with a DVT. The findings are present
on 3 contiguous slices of 5 mm in thickness and are matched
on the 2 pulse sequences. In addition, the left common iliac
vein is dilated, whereas the right common iliac vein (short ar-
rows) is normal. This patient’s leg vein duplex study was
normal.
response to an isolated calf vein DVT may need to be
modified when there is significant risk for the transmis-
sion of embolic material to the cerebral arterial
circulation.
Several features of the study generate caution when
generalizing to all patients with cryptogenic strokes. Most
patients in whom paradoxical embolisms were suspected
(Table 1) had diagnoses suggesting hypercoaguable con-
ditions, which are not likely the case in most stroke popu-
lations. This may have been due in part to the high rate of
neoplastic diseases among patients seen at UW. In most
cases, the sizes of the interatrial shunts were not mea-
sured. Such data might have provided greater insight into
stroke pathogenesis in patients with and without DVTs.
Moreover, the methods used to diagnosis the presence of
interatrial shunts may not have been optimal for the most
accurate measurement of shunt size.42
The current study identified 10 patients whose
cryptogenic strokes arose from paradoxical embolisms on
possible or probable bases. Unlike reports for pulmonary
embolism,38-40 isolated DVTs in the calf and pelvic veins
accounted for 50% of all patients, supporting the utility of
a broad assessment of subdiaphragmatic veins in the set-
ting of cryptogenic strokes and interatrial shunts. Sensitiv-
ity for DVTs may be improved by use of more than one
diagnostic technique. Prospective studies are needed to
better define the true prevalence of subdiaphragmatic
DVTs acutely after stroke.
We thank Kari Olmsted and Gerardo Ortiz for their assistance in prepar-
ing Figure 1.
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